Principal Financial Group
RVMD icon

Principal Financial Group’s Revolution Medicines RVMD Stock Holding History

Principal Financial Group’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,567
Closed -$444K – 2245
2026
Q1 		$444K Sell
4,567
-172
-4% -$17.4K ﹤0.01% 2034
2025
Q4 		$377K Sell
4,739
-1,656
-26% -$109K ﹤0.01% 2074
2025
Q3 		$299K Sell
6,395
-63,050
-91% -$2.47M ﹤0.01% 2119
2025
Q2 		$2.55M Buy
69,445
+56,653
+443% +$2.18M ﹤0.01% 1759
2025
Q1 		$452K Buy
12,792
+259
+2% +$10.5K ﹤0.01% 1944
2024
Q4 		$548K Sell
12,533
-414
-3% -$20.9K ﹤0.01% 1949
2024
Q3 		$587K Sell
12,947
-11,275
-47% -$491K ﹤0.01% 1917
2024
Q2 		$940K Sell
24,222
-6,005
-20% -$224K ﹤0.01% 1868
2024
Q1 		$974K Buy
30,227
+33
+0.1% +$978 ﹤0.01% 1870
2023
Q4 		$866K Buy
30,194
+5,614
+23% +$135K ﹤0.01% 1860
2023
Q3 		$680K Sell
24,580
-750
-3% -$22.2K ﹤0.01% 1896
2023
Q2 		$678K Buy
25,330
+2,773
+12% +$68K ﹤0.01% 1899
2023
Q1 		$489K Buy
22,557
+3,786
+20% +$93.2K ﹤0.01% 1970
2022
Q4 		$447K Buy
18,771
+2,099
+13% +$44.6K ﹤0.01% 2006
2022
Q3 		$329K Buy
16,672
+4,082
+32% +$89.7K ﹤0.01% 2056
2022
Q2 		$245K Buy
12,590
+4,255
+51% +$82.8K ﹤0.01% 2238
2022
Q1 		$213K Sell
8,335
-470
-5% -$10.2K ﹤0.01% 2323
2021
Q4 		$222K Sell
8,805
-5,534
-39% -$156K ﹤0.01% 2332
2021
Q3 		$394K Sell
14,339
-9,550
-40% -$278K ﹤0.01% 2240
2021
Q2 		$758K Buy
23,889
+128
+0.5% +$4.47K ﹤0.01% 2113
2021
Q1 		$1.09M Buy
23,761
+374
+2% +$16.8K ﹤0.01% 1977
2020
Q4 		$926K Buy
23,387
+17,565
+302% +$694K ﹤0.01% 1961
2020
Q3 		$203K Buy
+5,822
New +$161K ﹤0.01% 2206

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Principal Financial Group's RVMD Position: Q2 2026 in Review

Principal Financial Group sold out of Revolution Medicines (RVMD) in Q2 2026, closing a stake of 4,567 shares — an estimated $444K sold.

Principal Financial Group first reported a position in RVMD in Q3 2020 and held it in 23 quarters. The position peaked at $2.55M in Q2 2025. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Principal Financial Group reported no remaining Revolution Medicines position as of Q2 2026 after selling out during the quarter.
  • Principal Financial Group sold 4,567 Revolution Medicines shares in Q2 2026, an estimated $444K.
  • Principal Financial Group first reported a position in Revolution Medicines in Q3 2020 and held it in 23 quarters.
  • Principal Financial Group's Revolution Medicines position peaked at $2.55M in Q2 2025.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.